The trek for Women in IBD in Rome with @DrEmmaFlanagan & @SallyBell_IBD was 💯 worth it. A privilege to hear from, get to know & ask q’s of the world’s ‘likeable badass’ IBD women, in a supportive collaborative environment. Amazing work @MLongMD@JoanaTo62523004 & to the faculty
Fantastic presentation by Karim Fizazi! PEACE-1 at 7.7 years: adding abiraterone to ADT + docetaxel improved median OS to 6.2 vs 4.4 years (HR 0.68) in de novo mCSPC. Durable benefit from upfront intensification! @myESMO#ESMO26@oncoalert
FOURLIGHT-1 beautifully presented by @antgiorda
Fulvestrant + atirmociclib (cdk4i) vs Fulvestrant or exemestane + everolimus
All had prior CDK 4/6i
PFS 9.9 vs 6.6 HR 0.60 p=0.0007
@OncoAlert@DFCI_BreastOnc
Encouraging OS results in neuroendocrine prostate cancer at #ESMO26!
#KEYNOTE-365 evaluated pembrolizumab + carboplatin/etoposide vs chemotherapy alone.
• mOS: 10.2 vs 7.1 months (HR 0.33)
• rPFS: 5.1 vs 4.0 months (HR 0.66)
• PD-L1 CPS ≥1: mOS 11.0 vs 4.8 months (HR 0.16)
No new safety signals observed.
@myESMO@oncoalert
That's a wrap on our inaugural Breast Cancer EU Focus Meeting in Lisbon.
Two days at the SANA Malhoa with a great faculty from across Europe and the US, covering everything from HER2+ and TNBC to HR+ early and metastatic disease, ADC sequencing and risk-reducing strategies for BRCA1/2 carriers. The panel discussions were exactly what we hoped for: open, practical, and very much driven by the fellows in the room.
A big thank you to our co-chairs @VKaklamani and @JavierCortesMD for building such a strong program, and to all faculty for their time and contributions. Also to @TinnaCriss1, who managed this meeting from first draft to final session - a great job on a first edition.
Looking forward to the 2027 edition.
#BreastCancer#MedicalEducation#Oncology#Lisbon
Second day of @_MDEducation Breast Cancer EU Focus Meeting with answers to the predictive value of TILs in TNBC and the future of ADCs @lab_kok@hoperugo
Uploading the highlight video from the Breast Cancer Meeting two weeks ago — still feeling the thrill! The amazing feedback from the faculty made it even more special. Already excited for next year! ✨#breastcancer#livemeetings
Lung Cancer US Focus Meeting 2026 is officially complete — and what a fantastic event it was in Nashville!
A huge thank you to our chairs @StephenVLiu and @CharuAggarwalMD , faculty, fellows, supporters, attendees, and the on site team!
Already looking forward to next year!
Just 2 weeks to go until the Lung Cancer US Focus Meeting 2026 - and I’m really looking forward to it!
We’re bringing together a brilliant faculty and a highly engaged audience for two days of meaningful, discussion-driven exchange #LungCancer#projectmanagement#eventmanagement
After three incredible years, the Women in IBD EU Focus Meeting returns for its 4th edition in Rome! 🇮🇹
Co-chaired by @MLongMD and Joana Torres, MD and packed with an international faculty of outstanding women in IBD.
November 13–14, 2026 | Rome, Italy
🔗 md-education.com/women-in-ib…
At our Inaugural Breast Cancer US Focus Meeting, Ian Krop, MD highlighted the rapidly evolving HER2-positive breast cancer treatment landscape.
He returns for our 2nd Annual Meeting on April 24 - 25, 2026.
md-education.com/breast-canc…